Resolution of inflammation increases erythropoiesis.

Area of Science:

• Hematology and Immunology
• Lipid Mediators and Inflammation Resolution
• Developmental Biology

Background:

• Erythropoiesis, the process of red blood cell production, is crucial for oxygen transport, and its dysregulation leads to anemia.
• Bioactive lipid mediators, particularly specialized proresolving mediators (SPMs) derived from n-3 polyunsaturated fatty acids (n-3 PUFAs), are known for their role in inflammation resolution.
• The hematopoietic effects of SPMs, especially on erythropoiesis, remain largely unexplored.

Purpose of the Study:

• To investigate the impact of n-3 PUFA-derived SPMs on erythropoiesis.
• To identify specific SPMs that can enhance red blood cell production.
• To elucidate the molecular mechanisms underlying SPM-mediated erythropoiesis.

Main Methods:

• Screening of various n-3 PUFA-derived SPMs in zebrafish embryos to assess their effects on erythropoiesis.
• Quantitative analysis of erythrocyte and platelet production following treatment with identified SPMs.
• Metabolomic and RNA-sequencing analyses of sorted erythroid cells to understand cellular responses and gene expression changes.

Main Results:

• 7(S),17(S)-dihydroxydocosapentaenoic acid (7,17-diHDPAn-3) was identified as a potent enhancer of erythropoiesis, increasing erythrocyte numbers without affecting platelet production.
• Treatment with 7,17-diHDPAn-3 upregulated key erythroid markers like gata1 and genes involved in heme biosynthesis (hsp90), while downregulating genes associated with erythroid maturation (xpo1b).
• Co-administration with dexamethasone further amplified the expression of hematopoietic stem cell-associated genes, suggesting a synergistic effect potentially linked to inflammation resolution.

Conclusions:

• 7,17-diHDPAn-3 effectively promotes erythropoiesis in vivo, making it a potential therapeutic candidate for anemia.
• The identified SPM influences early hematopoietic development and erythroid cell metabolism, maintaining a viable cellular profile.
• These findings suggest a novel link between inflammation resolution pathways and the regulation of red blood cell production, opening new avenues for anemia treatment strategies.